Medical comms - Articles

Across the healthcare and pharmaceutical sectors, nothing is simultaneously as important for patient safety and operational efficiency as the supply chain.
Across the healthcare and pharmaceutical sectors, nothing is simultaneously as important for patient safety and operational efficiency as the supply chain. From manufacturers all the way to patients there are a large number of transactions, each carrying potential risks to both patient welfare and the bottom line of organisations in the chain. Businesses in the supply chain need to take a pro-active stance to make sure that everything runs as smoothly as possible.Whether it’s missing products, grey channel diversion or even outright fraud and counterfeiting, the impact that interference in the supply chain has can be enormous. You only…

The ability to sell yourself, develop new skills and offer relevant experience are just some of the ways you can stand out in today’s jobs market, according to recruiting experts Hays.
The ability to sell yourself, develop new skills and offer relevant experience are just some of the ways you can stand out in today’s jobs market, according to recruiting experts Hays.You should also prepare, dress appropriately and listen to the question asked to avoid common jobseeker mistakes.“Job numbers remain good in China but many jobseekers are failing to stand out and do themselves justice in today’s market,” says Simon Lance, Regional Director of Hays in China. “For instance, when they recruit an employer wants a proven performer who can hit the ground running and add immediate value to the bus…

There’s nothing like a tough market to force companies to take stock of their core business and reassess the best use of internal resources. Martin Magazzolo, global practice director of CSC Life Sciences’ Software Solutions Group, charts the move toward content as a service amid changing market dynamics.
Although life sciences organisations have a reputation for being conservative in outlook, keen to retain tight control over their information-based assets for fear they might otherwise compromise their competitive edge or customer safety, times have changed. With markets showing no immediate sign of recovery and competitive pressures fiercer than ever, pharma companies are finding they must rethink their business models if they want to secure their futures. And certain intensifying regulat…

2013 is tipped to be a milestone year for the global pharmaceutical industry. As a number of key blockbuster drugs face the expiry of their US patents over the next year, a strong opportunity opens up for manufacturers to launch their own generic versions in the US.
2013 is tipped to be a milestone year for the global pharmaceutical industry. As a number of key blockbuster drugs face the expiry of their US patents over the next year, a strong opportunity opens up for manufacturers to launch their own generic versions in the US. Since the US generics industry is currently worth approximately USD 73 billion and expected to increase to nearly USD 107 billion by 2016, 1 we’re likely to see a number of new entrants capitalizing on these growth prospects, especially from emerging countries lik…

The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. Lord Davies’ Women on Boards report outlined the benefits that a mixed board brings in terms of skills and different perspectives and recommended that a minimum of 25% of FTSE 100 board members should be female by 2015.
The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. Lord Davies’ Women on Boards report outlined the benefits that a mixed board brings in terms of skills and different perspectives and recommended that a minimum of 25% of FTSE 100 board members should be female by 2015. Across Europe the topic is also rising in importance, with a growing feeling that quotas may soon be imposed.How do…

Despite many pledges from Government to change the employment law landscape, this October’s legislative programme is a relatively quiet one for employment lawyers and employers.
Despite many pledges from Government to change the employment law landscape, this October’s legislative programme is a relatively quiet one for employment lawyers and employers. Many proposed statutory changes are still either currently before Parliament or still in the pipeline. However, as we look forward to October 2012 and beyond, there are still some changes employers should be aware of.AUTOMATIC PENSIONS ENROLMENT – 1 OCTOBER 2012From 1 October 2012, employers will be required to “auto-enrol” eligible employees not currently participating in a workplace pension scheme into either a qualifying pension scheme…

Becoming an employer of choice is vital to attract and retain staff especially given the current climate of increased competition for talent and employees, according to recruiting experts Hays in China.
Becoming an employer of choice is vital to attract and retain staff especially given the current climate of increased competition for talent and employees, according to recruiting experts Hays in China.There are many ways of being an employer of choice, which will position your organisation above the rest, and it doesn’t have to be a difficult process, according to Simon Lance, Regional Director of Hays in China.“It’s true that an organisation is only as good as the people who work there. Successful organisations have recognised they can achieve the employer of choice status through their p…

Digital marketing in the pharmaceutical & healthcare industry is reaching boiling point. After six or seven years of interest, it’s going mainstream – and instead of “should we go digital?”, pharma & healthcare companies are now asking “how do we do it successfully?”. We think the next seven years, leading up to 2020, will be crucial in this endeavour.
Digital marketing in the pharmaceutical & healthcare industry is reaching boiling point. After six or seven years of interest, it's going mainstream – and instead of "should we go digital?", pharma & healthcare companies are now asking "how do we do it successfully?". We think the next seven years, leading up to 2020, will be crucial in this endeavour.Featuring the views and experiences of industry experts from inside and outside of…

This case is part of a series of UK and European decisions on the issue of holiday and sickness absence and how domestic law (in the form of the Working Time Regulations 1998 (“WTR”)) interacts with EU case and legislative law.
Does a worker on sick leave have to give notice to carry over untaken leave?This case is part of a series of UK and European decisions on the issue of holiday and sickness absence and how domestic law (in the form of the Working Time Regulations 1998 (“WTR”)) interacts with EU case and legislative law. Now a UK case has come before the Court of Appeal looking at the contentious issue of whether a worker off sick has to request to carry over holiday they cannot take because of sickness, to another leave year – or do they “use it or lose it”?.Sickness and Holiday: a…

At the start of the Internet and the first ever internet domain name boom, why has ‘dot com’ become the king and not ‘dot net’?
At the start of the Internet and the first ever internet domain name boom, why has 'dot com' become the king and not 'dot net'? This is a serious naming question and demands authoritative clarity to the answers. Form a nomenclature point of view; the global audience felt more comfortable with .com. It sounded better and more like 'company' while, .et sounded weaker, limited, network related and therefore techie. Despite being half portion of the name of the Internet, the Net suffix was left behind, and although both were equally accessible the global perception got in the way. In usage, each dot Net also became the proof that somewhere out there an identical name…

Aberdeen scientists have demonstrated for the first time a clear link between sunlight, vitamin D and an impact on regulatory cells in the immune system in findings that might provide new insights into diseases such as multiple sclerosis (MS).
Aberdeen scientists have demonstrated for the first time a clear link between sunlight, vitamin D and an impact on regulatory cells in the immune system in findings that might provide new insights into diseases such as multiple sclerosis (MS).The research - published in the Journal of Allergy and Clinical Immunology – shows how UV (ultraviolet)-B light boosts vitamin D, as well as cells in our body that are responsible for regulating or balancing the immune system.Vitamin D is made in our bodies by UV-B light from the sun. Some studies have suggested…

Effective regulatory information management (Reg IM) is about so much more than compliance – or it could be, if only pharma organisations were tuned in to the wider commercial advantages. Yet, according to a recent survey, only 20% of life sciences companies have so far fully implemented a formal Reg IM strategy. Adam Sherlock, director at CSC Life Sciences, expresses his surprise
Effective regulatory information management (Reg IM) is about so much more than compliance – or it could be, if only pharma organisations were tuned in to the wider commercial advantages. Yet, according to a recent survey, only 20% of life sciences companies have so far fully implemented a formal Reg IM strategy. Adam Sherlock, director at CSC Life Sciences, expresses his surprise.In the data-dense world of pharma…

“First law on holes - when you're in one, stop digging!”
“First law on holes - when you're in one, stop digging!” Denis Healey, former UK Finance Minister.It is clear that Drug Discovery is in a “hole”. The worries about the patent cliff, and the slowing rate at which new drugs are discovered is well documented. So Denis Healey’s advice is pertinent. Instead of working feverishly harder at what has worked in the past, perhaps standing back to look more reflectively might be the way forward. In a way, standing back and being reflective is what Universities are for. So the University of Edinburgh is offering a Distance Learning course to take a fresh look at the problem.But this reflection is not from the ivory tower. Three people behind the course have close up experience of the rough-and-tu…

No, not the title of a new murder-mystery novel, but the facts of a case involving J Sainsbury PLC concerning the issue of “Vicarious Liability”. “Vicarious Liability” is the phrase used to describe the situation where a third party is responsible for acts committed, not by itself, but by another under its control.
No, not the title of a new murder-mystery novel, but the facts of a case involving J Sainsbury PLC concerning the issue of “Vicarious Liability”. “Vicarious Liability” is the phrase used to describe the situation where a third party is responsible for acts committed, not by itself, but by another under its control. Often in the employment relationship, the employer is said to be responsible (or vicariously liable) for the acts of its employees whilst they are “at work”. Howe…

The essential resource for implementing sustainable packaging labelling and artwork capabilities.
Packaging artwork is an often forgotten back room process in most pharmaceutical companies. However, the changing business environment has brought issues from this capability to the fore, as pharmaceutical and healthcare companies face one of the most difficult periods in their history.A new book from a former GlaxoSmithKline (GSK) head of global packaging design describes the key capabilities required to deliver right-first-time packaging artwork in today's environment. It also discusses potential future developments in the area to help the reader design any improvement activity with these in mind.It’s the essential resource for implementing sustainable packaging labelling and artwork capab…

A biologist’s job description may range widely depending on the area of specialty. A biologist is a scientist who studies life in one of its many forms, and a work settings can also range from a classical laboratory to field work in various environments and climates.
A biologist’s job description may range widely depending on the area of specialty. A biologist is a scientist who studies life in one of its many forms, and a work settings can also range from a classical laboratory to field work in various environments and climates.Biologists may study life on land, water, or air. They may study the smallest microbes or whole interlocking systems of life. Just a few of the possible kinds of biologists areAquatic biologists – Study all organisms, plats, and animals that live in waterMarine biol…

“Need a degree to get a pay rise – don’t bother if you’re 61 or older!” “Want to work beyond the age of 65 – afraid not, it’s in our Partnership Deed!” These may sound like the worst job adverts in the world, but in fact they are the subject matter of two cases whose judgments were handed down by the Supreme Court last week (25 April 2012). These key cases are set to challenge employer’s attitude to age and retirement.
“Want to work beyond the age of 65 – afraid not, it’s in our Partnership Deed!” These may sound like the worst job adverts in the world, but in fact they are the subject matter of two cases whose judgments were handed down by the Supreme Court last week (25 April 2012). These key cases are set to challenge employer’s attitude to age and retirement. What will these…

There has never been so much data in the world as there is now - how can pharmaceutical companies make sense of these increasing volumes of data, both for marketing and regulatory purposes? Stephen Dunnigan of business intelligence firm MicroStrategy looks at how technology can help unlock the potential of big data.
There has never been so much data in the world as there is now - how can pharmaceutical companies make sense of these increasing volumes of data, both for marketing and regulatory purposes? Stephen Dunnigan of business intelligence firm MicroStrategy looks at how technology can help unlock the potential of big data.The pharmaceutical industry has always been one that creates large volumes of data. The leading companies are large, multi-national organisations with an on-going an…

As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences.
As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences. In such an ever changing environment it is difficult to keep on top of what ‘best practice’ actually is, and how new technologies can enable more engaging conversations with stakeholders.The webcast has now become a standard part of the toolkit for communications teams to create connections between Key Opinion Leaders (KOLs), stakeholders and journalists. However with the c…

Oncology products dominate the global therapeutics market, and are on course to reach an estimated €56 billion in sales by 2015. While cultural differences in approaches to treatment and research into cancer undoubtedly exist between countries, investigators throughout the European Union have adopted similar approaches to the rigorous evaluations of novel oncology treatments in Phase I clinical trials. But such trials are not conducted without reference to a number of considerations.
Oncology products dominate the global therapeutics market, and are on course to reach an estimated €56 billion in sales by 2015.1 While cultural differences in approaches to treatment and research into cancer undoubtedly exist between countries, investigators throughout the European Union have adopted similar…